Skip to main content

Table 3 UVA for overall, distant-metastasis free, and progression-free survival

From: Smoking is predictive of poorer distant metastasis-free and progression free-survival in soft tissue sarcoma patients treated with pre-operative radiotherapy or chemoradiotherapy

Variable p-value
OS DMFS PFS
Age 0.0005 0.0218 NS
Smoking 0.05 0.0038 0.0151
Cardiovascular disease NS NS NS
Diabetes NS NS NS
High-grade 0.04 0.04 NS
Histology NS 0.02 NS
Karnofsky performance status NS NS NS
Tumor location 0.03 NS 0.0116
Tumor size 0.008 0.0088 0.0012
Chemotherapy NS NS NS
  1. NS not-significant